TAK-733
TAK-733 is a potent and selective MEK allosteric site inhibitor with an IC50 of 3.2 nM.
Product Specifications
CAS Number
1035555-63-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MEK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/TAK-733.html
Purity
99.79
Solubility
DMSO : ≥ 33 mg/mL
Smiles
O=C1C(C(NC2=CC=C(I)C=C2F)=C(F)C(N3C)=O)=C3N=CN1C[C@@H](O)CO
Molecular Formula
C17H15F2IN4O4
Molecular Weight
504.23
Precautions
H302, H315, H319, H335
References & Citations
[1]Dong Q, et al. Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer. Bioorg Med Chem Lett. 2011 Mar 1;21 (5) :1315-9.|[2]Micel LN, et al. Antitumor activity of the MEK inhibitor TAK-733 against melanoma cell lines and patient-derived tumor explants. Mol Cancer Ther. 2015 Feb;14 (2) :317-25.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
MEK
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC206009L4 10 µg
beta COP (COPB1) (NM_016451) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
EIA06210p 1 Kit
Porcine Prostaglandin D2 Synthase, Hematopoietic (PTGDS) ELISA Kit
Sign In for Pricing
View Details K0220802 1.0 µg DNA
C1QTNF6 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details